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majority of cardiac surgeons, and con-
sequently our findings reflect a ‘real-
world’ situation.’’
Lorenzo Guerrieri Wolf, MD
Bikram P. Choudhary, MRCS
Yasir Abu-Omer, MRCS
David P. Taggart, MD (Hons), PhD,
FRCS
Department of Cardiothoracic Surgery
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CONTEGRA AND
EXTRACARDIAC FONTAN
To the Editor:
We read with the greatest interest
the article entitled ‘‘Feasibility of the
Extracardiac Conduit Fontan Proce-
dure in Patients Weighing Less than
10 Kilograms.’’1 After congratulating
the authors for their excellent work,
we have a few comments.
As a Fontan Conduit, they used poly-
tetrafluoroethylene (Gore-Tex; WL
Gore & Associates Inc, Flagstaff, Ariz)
(14–20 mm in diameter) King Faisal
Specialist Hospital and Research Center
in Jeddah, used Contegra valved con-
duits in 4 patients for inferior vena
cava–right pulmonary artery connection
(Fontan). They speculated that an
additional benefit of using the Contegra
xenograft couldbe that itprovidesacom-
petent valve in the Fontan circulation,
which might help by reducing the rever-
sal of flow and maintaining better
forward flow into the pulmonary
circulation. The concern was whether
the valve, in a nonpulsatile, passive Fon-
tan circulation, would facilitate smooth
antegradeflow into thepulmonary circu-
lation or act as a source of resistance to
the flow. The findings that none of their
patients had hepatomegaly or ascites on
physical examination and that the post-
operative echocardiograms showed ex-
cellent antegrade flow in the inferior
vena cava, which also was not dilated,
and minimal flow reversal in the hepatic
veins support the facilitation of smooth
forward flow. They presented a new op-
tion for constructing an extracardiac
Fontan connection with the Contegra
xenograft that has not been previously
published.Their earlyechocardiographic
results supported the idea of minimiz-
ing the reversal of infradiaphragmatic
venous flow, decreasing hepatic con-
gestion, and possibly reducing the de-
velopment of ascites.2 They do have
a way of assessing the conduit size by
using Rowlatt and colleagues’ chart.3
The authors routinely administered 5
mg/kg ticlopidine as antiplatelet ther-
apy.Warfarinwas not used even though
they had a patient with arteriovenous
valve replacement. How did they con-
trol the thrombogenic potential here?
Measurement of the lower lobe in-
dex is an important adjunct to evaluate
candidates for the Fontan operation.
The predictive value of the Nakata in-
dex is less informative than the lower
lobe index, which was introduced to
optimize the preoperative selection of
Fontan candidates. Lower lobe index
may be more predictive to evaluate
the adequacy of the pulmonary vascu-
lar tree, given that central pulmonary
arteries used to calculate the Nakata in-
dex can be enlarged before or during
the Fontan operation.4
Sameh Ibrahim Sersar, MD
Ahmed A. Jamjoom, MD
Division of Cardiothoracic Surgery
Department of Cardiovascular
Diseases
King Faisal Specialist Hospital and
Research Center
Jeddah, Saudi Arabia
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We appreciate Dr Sersar’s com-
ments on our recent article, ‘‘Feasibil-
ity of the Extracardiac Conduit Fontan
Procedure in Patients Weighing Less
than 10 Kilograms.’’ These comments
raise several questions concerning the
following: (1) choice of conduit type,
(2) anticoagulation therapy after the
Fontan procedure, and (3) examination
of the pulmonary arteries for evaluat-
ing the pulmonary vascular tree.
In our article, we describe our strat-
egy for the extracardiac Fontan opera-
tion without fenestration. Our strategy
aimed to eliminate cyanosis as soon as
possible. Fenestration might reduce
the duration of pleural drainage but
cannot eliminate cyanosis even after
the Fontan procedure. We mentioned
in the article that peritoneal drainage
might be able to reduce the duration
of pleural drainage in small children
in particular. In addition to the obvious
purpose of the drainage of ascites it-
self, drainage of ascites also results in
the drainage of the inflammatory fac-
tors present in the ascites.1 In our se-
ries at least, there were no patients
with recurrent ascites after the cessa-
tion of the initial peritoneal drainage.
We have a chance to use a Contegra
conduit2 if this conduit is an attractive
option for reducing ascites and pleural
effusion. However, the use of this
conduit for the Fontan operation is
not permitted in Japan. The fate of
the conduit as a xenograft, especially
in terms of obstruction of conduit and
durability of valve function, over the
long term should be investigated.ry c Volume 136, Number 5 1393
tice of small cardiac units in the Middle
East and third world countries. Numer-
ous cardiac care units are located in sev-
eral hospitals throughout a single city,
and approximately 100 open surgeries
are performed each year in these units.
Many hospital administrations are rac-
ing and competing with each other to
provide this delicate and highly sophis-
ticated service without detailed under-
standing of the magnitude and finicial
commitment. It has to be emphesized
that cardiac surgery, although highly
needed and vital, is a complex, compre-
hensive and multidisciplinary subspe-
ciality. Vast financial resources are
needed to provide the nursing and med-
ical staff, and cardiology and cardiac
surgery equipment. Unfortunately,
there is no administrative collaboration
or even communication to obtain at
least a satisfactory output. These small
units share similar features and face
the same difficulties and obstacles, in-
cluding unsteady patient volume and
flow, and a series of average cases fol-
lowed by difficult high-risk cases. The
overall setup is substandard and aimed
for business, profit, and fame based
on the attraction of more patients cus-
tomers called to other subspecialties.
Emergency catheter laboratory compli-
cations add to the problems and in-
crease the surgical risk. Limited
intensive care beds, limited nurse/staff
coverage, and cardiac anesthesia short-
ages exist because these units are run
with limited resources and 1 or 2 anes-
thetists working 1 or 2 days per week
and involved with general surgery the
rest of the week.
Each cardiac case requires an exten-
sive arrangement of blood and blood
products, intensive care unit beds and
anesthesia during the day of surgery,
and night coverage at least for the first
Cardiac surgery cannot attain the
expected productivity unless the nec-
essary professionals and adequate re-
sources are provided. Full coverage,
24 hours per day, 7 days per week, of
diagnostic services, elective and emer-
gency operations, post operative fol-
lowup and rehabilitation, are crucial
for success of these programs.
Khaled E. Al-Ebrahim, MbbCh,
FRCSC
Division of Cardiac Surgery
King Abdulaziz
University Hospital
Department of Surgery
Jeddah, Saudi Arabia
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Reply to the Editor:
Dr Al-Ebrahim’s Letter to the Edi-
tor reinforces an important concept
from our article. The fact that some
lower-volume cardiac surgery pro-
grams have achieved excellent results
should not be viewed as a general en-
dorsement for developing more such
programs. The justification for any
new cardiac surgery program must
be critically evaluated, including the
adequacy of resources and referral
base.
Ideally, such new programs are
developed to serve populations who
have no other local or regional access
to cardiac surgery. To be successful,
Letters to the EditorWith regard to anticoagulation
agents, we did not previously use
warfarin in any small patients because
of the complexity of warfarin control.
However, we have recently used war-
farin in patients with artificial valve re-
placement or suboptimal conditions
after the Fontan operation.
Regardless of the methods used for
evaluating Fontan candidates, we be-
lieve that themost important evaluation
parameters are pulmonary vascular re-
sistance, pulmonary artery pressure,
and atrial pressure or ventricular end-di-
astolic pressure in patients undergoing
the bidirectional Glenn procedure. We
showed the Nakata index as the refer-
ence morphologic index for the pulmo-
nary vascular tree to comparewith other
study groups, because the body size of
our patients was relatively small and
there were no alternative conventional
indicators of the pulmonary vascular
tree.
Akio Ikai, MD
Iwate Medical University
Department of Cardiovascular
Surgery
Morioka, Japan
Kisaburo Sakamoto, MD
Shizuoka Children’s Hospital
Department of Cardiovascular
Surgery
Shizuoka, Japan
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CARDIAC UNITS
To the Editor:
We read with interest the recent
articles by Shahian and Normand1 and
Carey and colleagues2 and would like
to shed some light on the current prac-
night. The cardiac surgeon bears most
of the responsibility. Each morbidity
or mortality dramatically worsens the
results. The overall system arrange-
ment is suboptimal, with marginal
benefit and substantial cost.
Administrators and health providers
have to be aware of such problems.
smaller cardiac surgery programs
must be provided with the substantial
hospital resources necessary to care
for these complex patients. They
should also be encouraged to use the
strategies mentioned in our commen-
tary to help compensate for their
smaller volumes.
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